Comprehensive Data-Driven Analysis: AbbVie’s Financial Resilience, Strategic Transformation, and Next-Generation Drug Growth
AbbVie Inc. (ABBV), a pharmaceutical powerhouse with a market capitalization of $329.45 billion, presents a compelling case study in strategic pharmaceuticals management and financial resilience. Since its 2013 spin-off from Abbott Laboratories and subsequent acquisition of Allergan in 2020, AbbVie has navigated complex market dynamics while maintaining robust financial